OTCMKTS:BETRF BetterLife Pharma (BETRF) Stock Price, News & Analysis → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free BETRF Stock Alerts $0.07 0.00 (0.00%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$0.07▼$0.0750-Day Range$0.06▼$0.0852-Week Range$0.03▼$0.09Volume6,130 shsAverage Volume22,003 shsMarket Capitalization$7.97 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get BetterLife Pharma alerts: Email Address Ad WealthPress$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. About BetterLife Pharma Stock (OTCMKTS:BETRF)BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections. The company's products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to treat benzodiazepine dependency, anxiety, and neurodegenerative disorders. It is also developing MM-003, which has completed Phase II clinical trials for treatment of COVID-19 and other respiratory viral infections; and MM-001, a topical cream for local intravaginal use to treat HPV-induced cervical intraepithelial neoplasia that has completed Phase II clinical trials. The company was formerly known as Pivot Pharmaceuticals Inc. and changed its name to BetterLife Pharma Inc. in December 2019. BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada.Read More BETRF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BETRF Stock News HeadlinesMarch 4, 2024 | financialpost.comBetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton UniversityMarch 4, 2024 | globenewswire.comBetterLife's 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton UniversityMarch 29, 2024 | Behind the Markets (Ad)Central Banks Preparing for US Dollar Collapse?China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.December 18, 2023 | finance.yahoo.comBetterLife Announces Closing of a Private PlacementNovember 30, 2023 | finance.yahoo.comBetterLife Announces Extension of WarrantsNovember 15, 2023 | finance.yahoo.comUS Patent and Trademark Office Publishes BetterLife’s Comprehensive Patent for BETR-001 and Other LSD DerivativesNovember 9, 2023 | morningstar.comaTyr Pharma Inc LIFESeptember 14, 2023 | finance.yahoo.comBetterLife Pharma to Host Investors Update Call on September 18, 2023March 29, 2024 | DTI (Ad)the most reliable asset on earth is making a comebackGlobal tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.September 12, 2023 | finance.yahoo.comBetterLife Obtains Favourable Animal Safety Data for Repeated Oral Dosing of BETR-001September 5, 2023 | finance.yahoo.comBetterLife Highlights BETR-001 Article in Technology Networks Drug Discovery and Announces Closing of a Private PlacementJuly 13, 2023 | finance.yahoo.comBetterLife Highlights American College of Physicians’ Updated Guidelines for Treating Depression and Announces Closing of Private PlacementJune 27, 2023 | finance.yahoo.comBetterLife Fast Tracks Its US Patent for BETR-001 and Other LSD DerivativesJune 22, 2023 | finance.yahoo.comBetterLife To Present BETR-001 Preclinical Data at the 32nd Annual Meeting of the International Behavioural Neuroscience Society (IBNS) in Niagara Falls, Ontario, CanadaJune 9, 2023 | msn.comBetterLife's Non-Hallucinogenic LSD's Clinical Studies, Braxia's Psychedelic Treatments ContinueJune 8, 2023 | finance.yahoo.comBetterLife Continues Progress on BETR-001 IND-Enabling StudiesApril 25, 2023 | finance.yahoo.comBetterLife To Present BETR-001 Preclinical Data at the 2023 Annual Meeting of the Society of Biological Psychiatry (SOBP) in San Diego, CaliforniaApril 24, 2023 | finance.yahoo.comBetterLife Pharma to Present at the 2023 Bloom Burton & Co. Healthcare Investor ConferenceApril 20, 2023 | finance.yahoo.comBetterLife To Present at the 2023 Bloom Burton & Co. Healthcare Investor ConferenceMarch 29, 2023 | proactiveinvestors.comBetterLife Pharma says BETR-001 drug candidate featured in Drug Discovery & Development articleMarch 29, 2023 | finance.yahoo.comBetterLife's Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Drug Discovery & Development ArticleMarch 22, 2023 | finance.yahoo.comPromise of BetterLife's Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Medical Xpress ArticleMarch 14, 2023 | finance.yahoo.comCORRECTION -- BetterLife Closes $1,857,143 of Private PlacementMarch 14, 2023 | finance.yahoo.comBetterLife Closes $1,857,143 of Private PlacementMarch 13, 2023 | msn.comPsyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & MoreMarch 10, 2023 | finance.yahoo.comBetterLife Files Amended and Restated Offering Document for Offering of UnitsMarch 9, 2023 | msn.comMood Disorders Could Get An Alternative Treatment With This Next-Gen, Non-Hallucinogenic PsychedelicSee More Headlines Receive BETRF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BetterLife Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today3/29/2024Next Earnings (Estimated)5/28/2024Fiscal Year End1/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:BETRF CUSIPN/A CIK1464165 Webwww.abetterlifepharma.com Phone604-221-0595FaxN/AEmployees7Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,900,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-446.36% Debt Debt-to-Equity RatioN/A Current Ratio0.08 Quick Ratio0.08 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.05) per share Price / Book-1.40Miscellaneous Outstanding Shares113,820,000Free Float74,248,000Market Cap$7.97 million OptionableNot Optionable Beta1.38 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesDr. Ahmad Doroudian Ph.D. (Age 64)Founder, CEO & Chairman Comp: $221.44kMs. Moira Ong C.A. (Age 49)CPA, CA, CFA, Chief Financial Officer Comp: $194.87kDr. Hooshmand Sheshbaradaran Ph.D. (Age 56)Chief Operating Officer Comp: $246.48kDr. Stephen SanghaCorporate Development AdvisorMr. Scott Rudge Ph.D.Head of CMCAnthony Calandra Ph.D.Head of RegulatoryDr. Abdi Ghaffari Ph.D.Head of Preclinical & ToxicologyMore ExecutivesKey CompetitorsTrevenaNASDAQ:TRVNChemomab TherapeuticsNASDAQ:CMMBVirios TherapeuticsNASDAQ:VIRICyclerion TherapeuticsNASDAQ:CYCNAlterity TherapeuticsNASDAQ:ATHEView All Competitors BETRF Stock Analysis - Frequently Asked Questions How have BETRF shares performed in 2024? BetterLife Pharma's stock was trading at $0.0480 at the beginning of the year. Since then, BETRF stock has increased by 45.8% and is now trading at $0.07. View the best growth stocks for 2024 here. Are investors shorting BetterLife Pharma? BetterLife Pharma saw a drop in short interest during the month of February. As of February 29th, there was short interest totaling 2,400 shares, a drop of 92.8% from the February 14th total of 33,200 shares. Based on an average daily trading volume, of 35,600 shares, the short-interest ratio is presently 0.1 days. View BetterLife Pharma's Short Interest. When is BetterLife Pharma's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 28th 2024. View our BETRF earnings forecast. How do I buy shares of BetterLife Pharma? Shares of BETRF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:BETRF) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyOnly a fool would buy Nvidia today… Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BetterLife Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.